Advances in clinical management of COPD

Poster Discussion
Chairs: F. Franssen (Horn, Netherlands), B. Abascal Bolado (Santander (Cantabria), Spain)

Medical care according to risk level proposed by the new Spanish COPD Guidelines M. Erro Iribarren (Madrid, Spain), T. Alonso Pérez (Madrid, Spain), R. Gómez Punter (Madrid, Spain), E. Vázquez Espinosa (Madrid, Spain), E. García Castillo (Madrid, Spain), A. Roca Noval (Madrid, Spain), M. Pastor Sanz (Madrid, Spain), J. B Soriano (Madrid, Spain), J. Ancochea Bermúdez (Madrid, Spain)
Evaluation Of 24-Hour Day Respiratory Symptoms And GOLD Classification System In COPD Patients From Seven Latin America Countries: The LASSYC Study M. Montes De Oca (Caracas, Venezuela), A. Menezes (Pelotas, Brazil), F. Wehrmeister (Pelotas, Brazil), V. Lopez (Montevideo, Uruguay), L. Ramirez (San Jose, Costa Rica), M. Miravtlles (Barcelona, Spain)
Occupational exposures and Asthma-COPD overlap in a clinical cohort of adult-onset asthma M. Tommola (Seinäjoki and Jyväskylä, Finland), P. Ilmarinen (Seinäjoki, Finland), L. Tuomisto (Seinäjoki, Finland), L. Lehtimäki (Tampere, Finland), H. Kankaanranta (Seinäjoki and Tampere, Finland)
United airway: upper and lower respiratory symptoms of COPD patients V. Koblizek (Hradec Kralove, Czech Republic), B. Novotna (Praha, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), E. Volakova (Olomouc, Czech Republic), M. Svoboda (Brno, Czech Republic), P. Popelkova (Ostrava, Czech Republic), M. Plutinsky (Brno, Czech Republic), K. Brat (Brno, Czech Republic), P. Musilova (Jihlava, Czech Republic), J. Lnenicka (Praha, Czech Republic), L. Heribanova (Praha, Czech Republic), Z. Liptakova (Ceske Budejovice, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), P. Voglova (Mlada Boleslav, Czech Republic), P. Safranek (Plzen, Czech Republic), R. Simek (Zlin, Czech Republic), L. Nevoranek (Hradec Kralove, Czech Republic), M. Kopecky (Hradec Kralove, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), K. Neumannova (Olomouc, Czech Republic), M. Skrobackova (Brno, Czech Republic)
Fractionated exhaled nitric oxide in COPD patients D. Schumann (Basel, Switzerland), K. Kostikas (Basel, Switzerland), D. Schilter (Bern, Switzerland), R. Louis (Liege, Belgium), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
Differences of clinical characteristics and phenotype between biomass and tobacco related COPD A. YUKSEL (ANKARA, Turkey), F. Çi?ftçi? (ANKARA, Turkey)
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. K. Brat (Brno, Czech Republic), M. Plutinsky (Brno, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), E. Volakova (Olomouc, Czech Republic), M. Svoboda (Brno, Czech Republic), M. Skrobackova (Brno, Czech Republic), P. Popelkova (Ostrava, Czech Republic), B. Novotna (Prague, Czech Republic), V. Koblizek (Hradec Kralove, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), O. Kudela (Hradec Kralove, Czech Republic), P. Musilova (Jihlava, Czech Republic), K. Neumannova (Olomouc, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), P. Vanik (Ceske Budejovice, Czech Republic), M. Spruit (Maastricht, Netherlands), F. Franssen (Horn, Netherlands), L. Vanfleteren (Gothenburg, Sweden)
Influence of changes in physical activity (PA) and exercise capacity on mortality and quality of life (QL) in COPD A. Aramburu Ojembarrena (Galdakao, Spain), L. Chasco Eguilaz (Galdakao, Spain), A. Antón Ladislado (Galdakao, Spain), F. Moraza Cortés (Galdakao, Spain), M. Aburto Barrenechea (Galdakao, Spain), S. Aizpiri Rivero (Galdakao, Spain), P. Garcia Hontoria (Galdakao, Spain), C. Esteban Gonzalez (Galdakao, Spain)
Comparison between population with severe (ZZ) and intermediate (MZ) alpha1-antitrypsin deficiency and established COPD D. Piloni (Pavia, Italy), M. Mennitti (Pavia, Italy), L. Corda (Brescia, Italy), P. Baderna (Aosta, Italy), S. Ottaviani (Pavia, Italy), A. Balderacchi (Pavia, Italy), V. Barzon (Pavia, Italy), C. Tirelli (Pavia, Italy), F. Albicini (Pavia, Italy), F. Spreafico (Brescia, Italy), L. Saderi (Sassari, Italy), G. Sotgiu (Sassari, Italy), I. Ferrarotti (Pavia, Italy), A. Corsico (Pavia, Italy)
Does Aspergillus fungal sensitisation define asthma severity in difficult asthma? Findings from WATCH. H. Mistry (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), A. Freeman (Southampton, United Kingdom), M. Harvey (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), C. Newell (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom)
Predicting Recurrent Oral Corticosteroid Use in the WATCH cohort A. Freeman (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), H. Mistry (Southampton, United Kingdom), C. Newell (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), M. Harvey (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom)
Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes P. Tiew (Singapore, Singapore), F. Ko (Hong Kong, Hong Kong), H. Xu (Singapore, Singapore), M. Poh (Kuala Lumpur, Malaysia), J. Narayana (Singapore, Singapore), G. Sim (Singapore, Singapore), H. Neo (Singapore, Singapore), L. Loh (Penang, Malaysia), C. Ong (Penang, Malaysia), J. Tan (Singapore, Singapore), N. Kamaruddin (Kuala Lumpur, Malaysia), T. Lapperre (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), A. Tee (Singapore, Singapore), S. Chotirmall (Singapore, Singapore)
Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis W. Ban (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD). E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), A. Berdyugina (Barnaul, Russian Federation), I. Belova (Barnaul, Russian Federation)
Bone health of patients with COPD in relation to their exercise capacity and gait speed Z. Matkovic (Zagreb, Croatia), D. Cvetko (Zagreb, Croatia), D. Rahelic (Zagreb, Croatia), C. Esquinas (Barcelona, Spain), M. Žarak (Zagreb, Croatia), N. Tudoric (Zagreb, Croatia), M. Miravitlles (Barcelona, Spain)
Chronic bronchitis affects mortality in smokers with and without COPD U. Semenzato (Padova, Italy), D. Biondini (Padova, Italy), M. Bonato (Padova, Italy), M. Tinè (Padova, Italy), E. Bazzan (Padova, Italy), K. Lokar Oliani (Padova, Italy), J. Marin (Zaragoza, Spain), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy), G. Turato (Padova, Italy)
Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco as risk factor to cachexia. D. González Islas (Ciudad de México, Mexico), A. Orea Tejeda (Ciudad de México, Mexico), R. Hernández Zenteno (Ciudad de México, Mexico), L. Flores Cisneros (Ciudad de México, Mexico), R. Sánchez Santillán (Ciudad de México, Mexico), A. Ibarra Fernández (Ciudad de México, Mexico), S. Hernández López (Ciudad de México, Mexico), Y. Pilotzi Montiel (Ciudad de México, Mexico), F. Salgado Fernández (Ciudad de México, Mexico), A. Jiménez Valentín (Ciudad de México, Mexico)
Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD) H. Machida (Yamagata, Japan), H. Nakano (Yamagata, Japan), K. Sato (Yamagata, Japan), M. Sato (Yamagata, Japan), A. Igarashi (Yamagata, Japan), Y. Tokailin (Yamagata, Japan), S. Inoue (Yamagata, Japan), M. Watanabe (Yamagata, Japan)